Showing 1 - 13 results of 13 for search 'María José Galindo', query time: 0.06s
Refine Results
-
1
-
2
Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain. by Vanessa Castro-Granell, Noé Garin, Ángeles Jaén, Santiago Cenoz, María José Galindo, María José Fuster-RuizdeApodaca
Published 2021-01-01
Article -
3
Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain by Vanessa Castro-Granell, Noé Garin, Ángeles Jaén, Santiago Cenoz, María José Galindo, María José Fuster-RuizdeApodaca
Published 2021-01-01
Article -
4
Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART a... by María José Fuster-RuizdeApodaca, Vanessa Castro-Granell, Ana Laguía, Ángeles Jaén, Santiago Cenoz, María José Galindo
Published 2020-05-01
Article -
5
-
6
Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain. by Juan Ángel Patiño-Galindo, Manoli Torres-Puente, María Alma Bracho, Ignacio Alastrué, Amparo Juan, David Navarro, María José Galindo, Concepción Gimeno, Enrique Ortega, Fernando González-Candelas
Published 2017-01-01
Article -
7
Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV by Fátima Brañas, Miguel Torralba, Antonio Antela, Jorge Vergas, Margarita Ramírez, Pablo Ryan, Fernando Dronda, María José Galindo, Isabel Machuca, María Jesús Bustinduy, Alfonso Cabello, María Luisa Montes, Matilde Sánchez-Conde, FUNCFRAIL study group
Published 2023-01-01
Article -
8
Healthcare experience among patients with type 2 diabetes: A cross‐sectional survey using the IEXPAC tool by Domingo Orozco‐Beltrán, Sara Artola‐Menéndez, Antonio Hormigo‐Pozo, Daniel Cararach‐Salami, Juan Luis Alonso‐Jerez, Epifanio Álvaro‐Grande, Covadonga Villabrille‐Arias, Francisco Javier deToro‐Santos, María José Galindo‐Puerto, Ignacio Marín‐Jiménez, Antón Gómez‐García, Rocío Ledesma‐Rodriguez, Gonzalo Fernández, Karine Ferreira de Campos
Published 2021-04-01
Article -
9
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study. by Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer, Arkaitz Imaz, GESIDA-8314 Study Group
Published 2017-01-01
Article -
10
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV. by Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Sophie Marguet, Belén de la Fuente, Maria Jose Muñoz, Nadia Abdulghani, Esteban Ribera, Pere Domingo, Elisabeth Deig, Joaquim Peraire, Bernardino Roca, Marta Montero, Maria José Galindo, Alberto Romero, Nuria Espinosa, Fernando Lozano, María Dolores Merino, Elisa Martínez, Paloma Geijo, Vicente Estrada, Josefina García, M Antonia Sepúlveda, Juan Berenguer
Published 2021-01-01
Article -
11
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial. by Juan Pasquau, Carmen Hidalgo-Tenorio, María Luisa Montes, Alberto Romero-Palacios, Jorge Vergas, Isabel Sanjoaquín, José Hernández-Quero, Koldo Aguirrebengoa, Francisco Orihuela, Arkaitz Imaz, María José Ríos-Villegas, Juan Flores, María Carmen Fariñas, Pilar Vázquez, María José Galindo, Isabel García-Mercé, Fernando Lozano, Ignacio de Los Santos, Samantha Elizabeth de Jesus, Coral García-Vallecillos, QoLKAMON STUDY GROUP
Published 2018-01-01
Article -
12
Outcome of an HIV education program for primary care providers: Screening and late diagnosis rates. by Javier Martínez Sanz, María Jesús Pérez Elías, Alfonso Muriel, Cristina Gómez Ayerbe, María Jesús Vivancos Gallego, Matilde Sánchez Conde, Margarita Herrero Delgado, Pilar Pérez Elías, Lidia Polo Benito, Yolanda de la Fuente Cortés, Rafael Barea, Ann K Sullivan, Maria Jose Fuster Ruiz de Apodaca, María José Galindo, Santiago Moreno, DRIVE 03, OPTtest WP5 and FOCO Study Groups
Published 2019-01-01
Article -
13
Dolutegravir plus rilpivirine: benefits beyond viral suppression by Jesús Troya, MD, PhD, Carlos Dueñas, MD, Idoia Irazola, MD, Ignacio de los Santos, MD, PhD, Sara de la Fuente, MD, PhD, Desiré Gil, MD, PhD, Cristina Hernández, MD, María José Galindo, MD, PhD, Julia Gómez, MD, Elisabeth Delgado, MD, Estela Moreno-García, MD, Guillermo Posada, MD, PhD, Teresa Aldámiz, MD, PhD, Jose Antonio Iribarren, MD, José Manuel Guerra, MD, PhD, Miguel Ángel Morán, MD, Carlos Galera, MD, PhD, Javier Fuente, MD, Ana Peláez, MD, PhD, Miguel Cervero, MD, PhD, María Garcinuño, MD, Marta Montero, MD, Francisco Ceballos, PhD, Luis Buzón, MD, PhD, on behalf of the DORIPEX Study Group∗∗
Published 2022-06-01
Article